These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1758864)
1. [Use of dimephosphon in pathogenetic therapy of experimental tuberculosis]. Aleksandrova AE; Shcherbakova NM; Zabolotnykh NV; Shchegoleva RA Probl Tuberk; 1991; (8):68-71. PubMed ID: 1758864 [TBL] [Abstract][Full Text] [Related]
2. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314 [No Abstract] [Full Text] [Related]
3. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315 [No Abstract] [Full Text] [Related]
4. Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis. Bai KJ; Yu MC; Suo J; Chiang CY; Chiang IH; Lin TP; Luh KT J Formos Med Assoc; 1998 Apr; 97(4):278-82. PubMed ID: 9585680 [TBL] [Abstract][Full Text] [Related]
5. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
6. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis. Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740 [No Abstract] [Full Text] [Related]
7. [Combined use of antitubercular drugs and metabolites of the tricarboxylic acid cycle in experimental tuberculosis]. Sokirko TA; Maliuk VI; Klimenko MT; Suslov EI Probl Tuberk; 1990; (4):20-3. PubMed ID: 2395844 [TBL] [Abstract][Full Text] [Related]
8. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis. Mitchison DA Am J Respir Crit Care Med; 2003 May; 167(10):1298-9. PubMed ID: 12738593 [No Abstract] [Full Text] [Related]
9. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
10. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months. Trébucq A; Rieder HL Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189 [No Abstract] [Full Text] [Related]
11. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin. Grumbach F Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543 [No Abstract] [Full Text] [Related]
12. [Place of bacteriological examination in the treatment of tuberculosis]. Gyselen A Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438 [No Abstract] [Full Text] [Related]
13. Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis. Shoen CM; DeStefano MS; Sklaney MR; Monica BJ; Slee AM; Cynamon MH J Antimicrob Chemother; 2004 Apr; 53(4):641-5. PubMed ID: 14973154 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of tuberculosis]. Eier A; Grass S Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607 [TBL] [Abstract][Full Text] [Related]
15. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical]. Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100 [TBL] [Abstract][Full Text] [Related]
17. [Pathogenetic mechanisms of action of tarry substances and Mycobacterium tuberculosis in guinea pigs and rats]. Pavlov VA; Sabadash EV; Fadina OV; Mironova AL Probl Tuberk; 2002; (11):40-4. PubMed ID: 12501799 [TBL] [Abstract][Full Text] [Related]
18. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy]. Arnheim K Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689 [No Abstract] [Full Text] [Related]
19. Efficacy of Inhalations of Antituberculous Compositions with Different Length of Experimental Therapy Course in Mice. Shkurupy VA; Cherdantseva LA; Kovner AV; Troitskiy AV; Bystrova AV; Starostenko AA Bull Exp Biol Med; 2020 Apr; 168(6):743-747. PubMed ID: 32328933 [TBL] [Abstract][Full Text] [Related]
20. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Moulding T Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744 [No Abstract] [Full Text] [Related] [Next] [New Search]